Ohio Public Employees Retirement System (OPERS)
PTGX icon

Ohio Public Employees Retirement System (OPERS)’s Protagonist Therapeutics PTGX Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,014
Closed -$345K – 2010
2023
Q1 		$345K Hold
15,014
– – ﹤0.01% 1330
2022
Q4 		$164K Sell
15,014
-3,408
-18% -$28.8K ﹤0.01% 1422
2022
Q3 		$155K Buy
+18,422
New +$174K ﹤0.01% 1518
2020
Q2 		– Sell
-2,943
Closed -$21K – 1938
2020
Q1 		$21K Buy
2,943
+43
+1% +$322 ﹤0.01% 1781
2019
Q4 		$20K Buy
+2,900
New +$28.8K ﹤0.01% 1847

Other funds holding PTGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s PTGX Position: Q2 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Protagonist Therapeutics (PTGX) in Q2 2023, closing a stake of 15,014 shares — an estimated $345K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in PTGX in Q4 2019 and held it in 5 quarters. The position peaked at $345K in Q1 2023. 167 funds tracked by Wall St. Rank hold PTGX as of Q2 2023.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Protagonist Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 15,014 Protagonist Therapeutics shares in Q2 2023, an estimated $345K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Protagonist Therapeutics in Q4 2019 and held it in 5 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Protagonist Therapeutics position peaked at $345K in Q1 2023.
  • 167 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2023, filed 15 Aug 2023.